-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Integra Lifesciences, Lowers Price Target to $13

Benzinga·10/26/2026 14:44:10
Listen to the news
Truist Securities analyst Ravi Misra maintains Integra Lifesciences (NASDAQ:IART) with a Hold and lowers the price target from $15 to $13.